Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00026780 · ClinicalTrials.gov registry record
Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,720
- Enrollment target
NCT00026780: Completed study, sponsored by National Cancer Institute (NCI).
NCT00026780 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,720 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00026780 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,720 participants
- Enrollment target
Study Summary
Patients who are being considered for participation in a NCI Pediatric Oncology Branch research study will be screened for eligibility under this protocol. For every NCI research study, patients must meet defined medical criteria in order to ensure the integrity of the research study and to maximize patient safety. Tests and procedures required for determining eligibility depend on the specific study for which the patient is being considered. Some of the more common tests and procedures are: * History and physical examination * Blood and urine samples for routine laboratory tests and possibly research studies * Quality of life assessment questionnaire * Magnetic resonance imaging (MRI) scan uses a magnetic field and radio waves to produce pictures of body structures, including tumors * Computerized tomography (CT) scan uses radiation to produce multiple detailed pictures of body structures * X-rays uses radiation to provide a single picture of a body part * Nuclear medicine scans uses a chemical tagged with a radioactive substance to detect tumors, measure kidney or heart function, or monitor the flow of cerebrospinal fluid (fluid that bathes the brain and spinal cord) * Electrocardiogram (EKG) uses electrodes placed on the skin to evaluates heart rate and rhythm by measuring electrical impulses from the heart * Echocardiogram uses high-frequency sound waves to evaluate heart structure and function * Lumbar puncture tests for cancer cells and other substances in cerebrospinal fluid. Involves placing a needle into the lower back between the bones of the spine and withdrawing a fluid sample from the fluid-containing space below the spinal cord * Ommaya reservoir surgically implanted catheter inserted into the fluid-filled ventricles of the brain, used to withdraw spinal fluid samples and to give medication * Eye examination vision test and eye examination * Biopsies removal of a small piece of tissue, by needle or by surgery, for examination under the microscope. An
Primary Outcome
Eligibility
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,720 participants |
| Start Date | 2001-09-24 |
| Est. Completion | 2020-10-07 |
What the finished NCT00026780 record still lists
NCT00026780 is an observational study that tracks outcomes without assigning an intervention. Its 1,720 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00026780 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00026780 about?
NCT00026780 is a clinical study titled "Eligibility Screening for a NCI Pediatric Oncology Branch Research Study". Patients who are being considered for participation in a NCI Pediatric Oncology Branch research study will be screened for eligibility under this protocol. For every NCI research study, patients must meet defined medical criteria in order to ensure the integrity of the research study and to maximize...
What is the current status of trial NCT00026780?
This trial is currently completed. The enrollment target is 1,720 participants. The study started on 2001-09-24. Estimated completion is 2020-10-07.
Who is sponsoring clinical trial NCT00026780?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06898034 · 1,725 participants
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- NCT06413420 · 1,731 participants
SUNOSI® (Solriamfetol) Pregnancy Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI